Table 3 Multivariate analysis adjusting gender and age of independent factors in Jin’s model.

From: Development and validation of a blood routine-based extent and severity clinical decision support tool for ulcerative colitis

 

Internal validation set

External validation set

OR

0.95 CI

Adjusted P

OR

0.95 CI

Adjusted P

Montreal classification

 E2 vs. E1

  WBC

1.310

1.061–1.617

0.012

1.711

1.376–2.128

 < 0.001

  RDW-CV

1.481

1.012–2.168

0.043

2.219

1.486–3.314

 < 0.001

 E3 vs. E1

  LYMPH%

0.933

0.888–0.981

0.007

0.922

0.890–0.955

 < 0.001

  EO

82.632

1.644–4152.692

0.027

395.343

18.531–8434.143

 < 0.001

Severity

 Mayo score

  WBC

Remission/mild

1

     

Moderate

1.175

1.046–1.319

0.006

1.364

1.196–1.566

< 0.001

Severe

1.571

1.321–1.869

 < 0.001

1.446

1.253–1.669

< 0.001

  HCT

Remission/mild

1

     

Moderate

0.875

0.820–0.934

 < 0.001

0.944

0.898–0.993

0.026

Severe

0.725

0.646–0.813

 < 0.001

0.860

0.810–0.914

< 0.001

 Mayo endoscopic score

  NEUT

  

0.140

1.200

1.023–1.047

0.025

  HCT

0.902

0.847–0.960

0.001

0.904

0.843–0.971

0.005

 DUBLIN score

  WBC

1.149

1.039–1.271

0.007

1.668

1.384–2.011

< 0.001

  RBC

0.274

0.146–0.512

< 0.001

0.437

0.249–0.765

0.004

  1. E2 vs. E1 presents distinguish left-sided from proctitis, E3 vs. E1 presents distinguish extensive from proctitis.
  2. CI confidence interval, CV coefficient of variation, DUBLIN degree of ulcerative colitis burden of luminal inflammation, HCT haematocrit, HGB haemoglobin, NEUT neutrophil, OR odds ratio, RBC red blood cell, RDW red cell distribution width, WBC white blood cell.
Back to article page